These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26728665)

  • 1. Predictive value of recurrence for serum hypoxia inducible factor-1α C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
    Jing Q; Jianyong L; Jiming Y; Shuren L; Rui W; Wei L
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e105-6. PubMed ID: 26728665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
    Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
    Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
    Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
    J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between serum hypoxia inducible factor-1α, vascular endothelial growth factor and computed tomography perfusion imaging at pre-and post-TACE in patients with primary hepatic carcinoma].
    Jia ZZ; Huang YQ; Feng YL; Jiang GM
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1472-5. PubMed ID: 24029570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.
    Xu W; Kwon JH; Moon YH; Kim YB; Yu YS; Lee N; Choi KY; Kim YS; Park YK; Kim BW; Wang HJ
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1507-15. PubMed ID: 24853275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Pinto E; Pelizzaro F; Cardin R; Battistel M; Palano G; Bertellini F; Kitenge MP; Peserico G; Farinati F; Russo FP
    Dig Liver Dis; 2024 May; 56(5):872-879. PubMed ID: 37783655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of transcatheter arterial chemoembolization combined with surgery in the treatment of hepatocellular carcinoma.
    Feng L; Jin-Hua Z; Yong-Yi Z; Jing-Feng L
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e99-101. PubMed ID: 26728684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer.
    Jia ZZ; Jiang GM; Feng YL
    Chin Med Sci J; 2011 Sep; 26(3):158-62. PubMed ID: 22207924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
    Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive values of serum dickkopf-1 and circulating tumor cells in evaluating the efficacy of transcatheter arterial chemoembolization treatment on hepatocellular carcinoma.
    Wu X; Yang C; Yu H; Cao F; Shan Y; Zhao W
    Medicine (Baltimore); 2019 Jul; 98(30):e16579. PubMed ID: 31348291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma.
    Wu H; Liu S; Zheng J; Ji G; Han J; Xie Y
    J Surg Oncol; 2015 Sep; 112(4):372-6. PubMed ID: 26368066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
    Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
    Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
    Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
    Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of post-operative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics].
    Xi T; Yan ZL; Wang K; Li J; Xia Y; Shen F; Wu MC
    Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):587-90. PubMed ID: 17688789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
    Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
    J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
    Minami Y; Minami T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Tsurusaki M; Yagyu Y; Ueshima K; Nishida N; Murakami T; Kudo M
    Oncology; 2015; 89 Suppl 2():27-32. PubMed ID: 26584033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.